Key points are not available for this paper at this time.
specificity. These results indicate the potential of Trastuzumab-ICG for high-specificity detection of HER2-positive breast cancer and its lymph node metastases, offering a promising tool for high-contrast tumor visualization and personalized treatment guidance.
Liu et al. (Wed,) studied this question.